{
    "SPADE_UN_12050": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_12050",
            "Peptide Name": "3L (Derived from PMAP-36)",
            "Source": "synthetic construct",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "LRLRLKTRLRLK",
            "Sequence Length": 12,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Synthetic form",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "[Ref.31276398] Gram-positive bacteria:Staphylococcus aureus 29213 (MIC=32 μM), Staphylococcus aureus 25923 (MIC=32 μM), Staphylococcus  epidermidis 12228 (MIC=64 μM);Gram-negative bacteria:Escherichia coli 25922 (MIC=4 μM), Escherichia coli 1005 (MIC=4 μM), Staphylococcus typhi (MIC=16 μM)",
            "Hemolytic Activity": "[Ref.31276398] MHC>128μM. The minimum hemolytic concentration (MHC) is measured as the lowest concentration of the peptides that caused 5% hemolysis of human red blood cells (hRBCs).",
            "Cytotoxicity": "[Ref.31276398] The cell viability of the murine macrophage cell line RAW264.7 induced by 3L is 95.9%, 92.4%, 91.6%, 82.1%, 104.3%, 97.1%, 99.5% and 96.6% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 and 128 μM",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Amidation",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C70H136N26O14",
            "Mass": 1565.99,
            "PI": 12.0,
            "Net Charge": 6,
            "Hydrophobicity": -0.63,
            "Half Life": "Mammalian:5.5 hourYeast:3 minE.coli:2 min",
            "Function": "Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria.",
            "Literature": [
                {
                    "Title": "Design of Trp-rich dodecapeptides with broad-spectrum antimicrobial potency and membrane-disruptive mechanism",
                    "Pubmed ID": "31276398",
                    "Reference": "J Med Chem. 2019 Aug 8;62(15)6941-6957. doi 10.1021/acs.jmedchem.9b00298.",
                    "Author": "Lyu Y, Chen T, Shang L, Yang Y, Li Z, Zhu J, Shan A.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=31276398"
                }
            ],
            "Frequent Amino Acids": "LRK",
            "Absent Amino Acids": "ACDEFGHIMNOPQSUVWY",
            "Basic Residues": 6,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 5,
            "Polar Residues": 7,
            "Positive Residues": 6,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_10919",
                    "Similarity": 1.0,
                    "Sequence": "LRLR"
                },
                {
                    "SPADE_ID": "SPADE_N_11403",
                    "Similarity": 1.0,
                    "Sequence": "LRLKG"
                },
                {
                    "SPADE_ID": "SPADE_N_11407",
                    "Similarity": 1.0,
                    "Sequence": "LRLR"
                }
            ]
        }
    }
}